FDA Approves Bepirovirsen, First Antisense Therapy for Chronic Hepatitis B
FDA Approves Bepirovirsen, First Antisense Therapy for Chronic Hepatitis B Contagion Live
2026
FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease
FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease Pharmaceutical Technology
FDA Approval of Dostarlimab Brings Potential Organ-Sparing Approach in dMMR Locally Advanced Rectal Cancer
FDA Approval of Dostarlimab Brings Potential Organ-Sparing Approach in dMMR Locally Advanced Rectal Cancer OncLive
FDA Approves Hibsago | PharmExec
FDA Approves Hibsago | PharmExec Pharmaceutical Executive